In a report published Tuesday, Bank of America Merrill Lynch analyst Andrew Obin upgraded Danaher Corporation DHR to Buy from Neutral, raising its price objective to $90.00 from $78.00.
According to the report, the price objective rise reflects higher comparable trading multiples, as well as higher probability of DHR stepping up acquisition size in 2014.
“We upgrade DHR from a Neutral to a Buy heading into '14 reflective of: 1) A likely step-up in the company's acquisition pace with the integration of Beckman Coulter largely complete; 2) Improving core growth which should provide EPS upside relative to DHR's conservative outlook next year; 3) An attractive EV/EBITDA valuation relative to peers, considering premium returns and EPS upside from M&A,” the report noted.
DHR closed Tuesday at $76.15 with shares trading down at 1.97 percent.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in